Trial Profile
Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC): a single centre prospective double-blind randomised controlled trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 May 2022
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Cefuroxime
- Indications Bacterial infections; Endophthalmitis
- Focus Therapeutic Use
- Acronyms SILC
- 22 Nov 2018 Status has been changed to discontinued.
- 02 Oct 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 15 Jun 2010 Planned end date changed from 31 Aug 2010 to 1 Oct 2011 as reported by ISRCTN: Current Controlled Trials record.